Sequencing to Function: Analysis and Applications for the Future Meeting

conference logo showing DNA strand
  • September 28, 2021: virtual “teaser” meeting Part 1
  • March 15, 2022: virtual "teaser" meeting Part 2
  • June 21-23, 2022: in-person meeting in Santa Fe, NM
Register via Eventbrite
Download invitation PDF


“Sequencing to Function: Analysis and Applications for the Future” (SFA2F) is an annual meeting dedicated to bringing together experts in the genomics field—including representatives from the industries that serve this specialized scientific community.  

The SFA²F conference focuses on Next Generation Sequencing technologies, applications, and their effect on the rapidly advancing field of genomics.

Keynote Speakers:

  • Karen Miga, Director, Assistant Professor in the Biomolecular Engineering Department at University of California at Santa Cruz (UCSC) and Associate Director at the UCSC Genomics Institute.
  • Sharon Peacock, Professor of Public Health and Microbiology in the Department of Medicine, University of Cambridge, and Executive Director and Chair of the COVID-19 Genomics UK (COG-UK) consortium.
  • Jurgen Richt, Director of the Center of Excellence for Emerging and Zoonotic Animal Diseases and Director of the NIH COBRE Center on Emerging and Zoonotic Infectious Diseases (CEZID).

Areas of emphasis

Genome Sequencing

  • Sequencing strategies and technology advancements using the various NGS platforms
  • De novo sequencing, re-sequencing, Human seq., RNA seq., metagenomics, etc.
  • Sequencing applications for single cell, metagenomics, transcriptomics, diagnostics, and biosurveillance

Genome Assembly

  • De novo assemblers for short reads, hybrid assemblers
  • Recalling and calibrating genome assemblies
  • Single cell and metagenomic assemblies

Genome Analysis

  • Comparative genomics, re-sequencing, SNPs, structural variation
  • Large scale data management, cloud computing
  • Analysis for forensics, metagenomics, and antimicrobial resistance

Applications of NGS

  • Bringing sequence to the clinic (i.e., diagnostics, cancer, inherited disorders)
  • Human, non-human, and infectious disease applications
  • Gene editing, synthetic genomics, forensics, biosurveillance, and cyberbiosecurity
  • AgriGenomics, livestock genomics, plant genomics
  • Global engagement and partnerships